Clinical trials for the vaccine produced by Oxford and AstraZeneca show that it is 79% effective against COVID-19
Clinical trials for the vaccine produced by Oxford and AstraZeneca show that it is 79% effective against COVID-19.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthClinical trials for the vaccine produced by Oxford and AstraZeneca show that it is 79% effective against COVID-19
View Premium plansBrowse free archive reportsClinical trials for the vaccine produced by Oxford and AstraZeneca show that it is 79% effective against COVID-19.